SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
小M
Lv6
1720 积分
2024-05-17 加入
最近求助
最近应助
互助留言
A Study of Dupilumab in Adults with CRSsNP: Results from the Liberty ORION study
1天前
待确认
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
2天前
已完结
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
6个月前
已完结
Safety profile of proprotein convertase subtilisin/kexin type 9 inhibitors alirocumab and evolocumab: an updated meta-analysis and meta-regression
7个月前
已完结
Safety of Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies in Regard to Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials
7个月前
已完结
Long-term efficacy and safety of proprotein convertase subtilisin/kexin 9 monoclonal antibodies: A meta-analysis of 11 randomized controlled trials
7个月前
已完结
Inclusion of Smoking Data in Cardiovascular Disease Risk Estimation
9个月前
已完结
Independence of clinical events committees: A consensus statement from clinical research organizations
10个月前
已完结
Clinical events classification (CEC) in clinical trials: Report on the current landscape and future directions — proceedings from the CEC Summit 2018
10个月前
已完结
Fourth universal definition of myocardial infarction (2018)
10个月前
已完结
没有进行任何应助
Safety profile of proprotein convertase subtilisin/kexin type 9 inhibitors alirocumab and evolocumab: an updated meta-analysis and meta-regression.标题是这个
7个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论